312 related articles for article (PubMed ID: 21193056)
1. Donor lymphocyte infusion may reduce the incidence of bronchiolitis obliterans after allogeneic stem cell transplantation.
Forslöw U; Mattsson J; Gustafsson T; Remberger M
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1214-21. PubMed ID: 21193056
[TBL] [Abstract][Full Text] [Related]
2. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W
Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967
[TBL] [Abstract][Full Text] [Related]
3. Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning.
Yoshihara S; Tateishi U; Ando T; Kunitoh H; Suyama H; Onishi Y; Tanosaki R; Mineishi S
Bone Marrow Transplant; 2005 Jun; 35(12):1195-200. PubMed ID: 15852024
[TBL] [Abstract][Full Text] [Related]
4. Recipient NOD2/CARD15 variants: a novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation.
Hildebrandt GC; Granell M; Urbano-Ispizua A; Wolff D; Hertenstein B; Greinix HT; Brenmoehl J; Schulz C; Dickinson AM; Hahn J; Rogler G; Andreesen R; Holler E
Biol Blood Marrow Transplant; 2008 Jan; 14(1):67-74. PubMed ID: 18158963
[TBL] [Abstract][Full Text] [Related]
5. Bronchiolitis obliterans following pediatric allogeneic hematopoietic stem cell transplantation.
Duncan CN; Buonanno MR; Barry EV; Myers K; Peritz D; Lehmann L
Bone Marrow Transplant; 2008 Jun; 41(11):971-5. PubMed ID: 18297116
[TBL] [Abstract][Full Text] [Related]
6. Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children.
Nishio N; Yagasaki H; Takahashi Y; Muramatsu H; Hama A; Tanaka M; Yoshida N; Watanabe N; Kudo K; Yoshimi A; Kojima S
Bone Marrow Transplant; 2009 Sep; 44(5):303-8. PubMed ID: 19349954
[TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
8. Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation.
Uhlving HH; Andersen CB; Christensen IJ; Gormsen M; Pedersen KD; Buchvald F; Heilmann C; Nielsen KG; Mortensen J; Moser C; Sengeløv H; Müller KG
Biol Blood Marrow Transplant; 2015 Mar; 21(3):531-8. PubMed ID: 25498923
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphocytic leukemia].
Ma X; Wu DP; Sun AN; Fu ZZ; Tang XW; Wu XJ; Liu YJ; Qiu HY; Miao M; Han Y; Jin ZM; Zhao Y; Xue SL; Wang Y; Chen SN; He GS; Zhou HX; Chang HR
Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):73-6. PubMed ID: 19563014
[TBL] [Abstract][Full Text] [Related]
10. Small airways function declines after allogeneic haematopoietic stem cell transplantation.
Lahzami S; Schoeffel RE; Pechey V; Reid C; Greenwood M; Salome CM; Berend N; King GG
Eur Respir J; 2011 Nov; 38(5):1180-8. PubMed ID: 21565912
[TBL] [Abstract][Full Text] [Related]
11. Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation.
Patriarca F; Skert C; Sperotto A; Damiani D; Cerno M; Geromin A; Zaja F; Stocchi R; Prosdocimo S; Fili' C; Fanin R
Bone Marrow Transplant; 2004 Apr; 33(7):751-8. PubMed ID: 14755316
[TBL] [Abstract][Full Text] [Related]
12. Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight--new perspectives?
Ditschkowski M; Elmaagacli AH; Koldehoff M; Gromke T; Trenschel R; Beelen DW
Bone Marrow Transplant; 2013 Sep; 48(9):1224-9. PubMed ID: 23435515
[TBL] [Abstract][Full Text] [Related]
13. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.
Schmid C; Labopin M; Nagler A; Bornhäuser M; Finke J; Fassas A; Volin L; Gürman G; Maertens J; Bordigoni P; Holler E; Ehninger G; Polge E; Gorin NC; Kolb HJ; Rocha V;
J Clin Oncol; 2007 Nov; 25(31):4938-45. PubMed ID: 17909197
[TBL] [Abstract][Full Text] [Related]
14. Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT).
Michallet AS; Nicolini F; Fürst S; Le QH; Dubois V; Hayette S; Bourgeot JP; Tremisi JP; Thomas X; Gebuhrer L; Michallet M
Bone Marrow Transplant; 2005 Mar; 35(6):601-8. PubMed ID: 15756285
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of donor lymphocyte infusion in patients after different types of allogeneic hematopoietic stem cell transplantation].
Slesarchuk OA; Babenko EV; Semenova EV; Bondarenko SN; Éstrina MA; Morozova EV; Paina OV; Vavilov VN; Smirnov BI; Zubarovskaia LS; Afanas'ev BV
Ter Arkh; 2013; 85(7):26-33. PubMed ID: 24137944
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.
Rupa-Matysek J; Lewandowski K; Nowak W; Sawiński K; Gil L; Komarnicki M
Transplant Proc; 2011 Jun; 43(5):1915-23. PubMed ID: 21693300
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia.
Santo Tomas LH; Loberiza FR; Klein JP; Layde PM; Lipchik RJ; Rizzo JD; Bredeson CN; Horowitz MM
Chest; 2005 Jul; 128(1):153-61. PubMed ID: 16002929
[TBL] [Abstract][Full Text] [Related]
19. Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation.
Baron F; Siquet J; Schaaf-Lafontaine N; Baudoux E; Hermanne JP; Fillet G; Beguin Y
Haematologica; 2002 Jan; 87(1):78-88. PubMed ID: 11801468
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
